SRT for Residual Oligometastases of NSCLC After 3rd Generation EGFR-TKIs

Clinical trial NCT04764214 · COMPLETED

Trial details

NCT number: NCT04764214
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IV EGFR Activating Mutation

Start date: 2021-03-01
Primary completion: 2023-03-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.